Cytopenias, such as anemia, neutropenia and thrombocytopenia are frequent complications seen in 40-60% of T-LGL leukemia cases owing to the production of anti-granulocyte antibodies or high circulating concentration of soluble FAS-ligand (14, 48, 58). This evidence concerns the gene FAS and Decreased total neutrophil count.